Email address
[email protected]Contact number
+44 20 7405 1111Share profile
Band 2
Band 2
About
Provided by Thomas Hinchliffe KC
Practice Areas
All aspects of contentious intellectual property, with a particular emphasis on patent litigation in the pharmaceutical, biotechnology and mobile telephony fields. Recent notable cases include: Samsung v Janssen [2024]; ACD v MI [2024], Bayer v Aspire [2024]; Phillips v Oppo [2023]; IPCom v Vodafone [2023]; Nokia v Oppo [2022]; Optis v Apple [2022]; Alcon v AMO [2021]; Teva v Janssen [2021]; InterDigital v Lenovo [2021] & [2022]; Illumina v MGI [2020]; IPCom v HTC [2020]; MSD v Wyeth [2020]; Conversant v Huawei [2020]; Aspire & Accord [2019]; Emson v Hozelock [2020] & [2019]; Philips v Asus [2018]; Merck v Comptroller [2017]; Illumina v Premaitha [2017]; Merck v Teva [2017], Novartis v Actavis [2016]; Lilly v Actavis [2016]; Hospira v Cubist [2017 & 2016]; Unwired Planet v Samsung [2016]; Merck v Ono [2015]; Vringo v ZTE [2014]; Philips v Nintendo [2014]; Samsung v Apple [2013]; Perini v PCMC [2012]; Generics v Yeda [2012]; Merck v Sigma [2012]; Warner- Lambert v Teva [2011]; Datacard v Eagle [2011]; Abbott v Medinol [2010]; RIM v Motorola [2010]; Generics UK v Daiichi [2009]; Actavis v Merck [2008]; Generics v Lundbeck [2008]; Qualcomm v Nokia [2008]; Conor v Angiotech [2007].
Career
Called to the Bar 1997. Took silk in 2016. Editor of the 18th -20th editions of Terrell on the Law of Patents.
Professional Memberships
Intellectual Property Bar Association; Chancery Bar Association.
Personal
Brasenose College Oxford (1995 MA, Chemistry).